A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: TQB3616
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.